Pretreatment of NSCLC U-1810 cells with CHX did not reduce compound 1-induced PARP-1 cleavage, suggesting that compound 1 is not likely to primarily mediate its IGF-1R blocking effect by alteration of transcription (Figure 1D). The gene discussed is IGF1R; the disease is non-small cell lung carcinoma.